{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:55:59Z","timestamp":1792691759726,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0811-y","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T22:55:24Z","timestamp":1456959324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Cai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"issue":"2","key":"811_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"9573","key":"811_CR2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(07)60723-5","volume":"369","author":"J Liu","year":"2007","unstructured":"Liu J, Fan D. Hepatitis B in China[J]. Lancet. 2007;369(9573):1582\u20133.","journal-title":"Lancet"},{"issue":"4","key":"811_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00432-003-0511-1","volume":"130","author":"ZY Tang","year":"2004","unstructured":"Tang ZY, Ye SL, Liu YK, et al. A decade\u2019s studies on metastasis of hepatocellular carcinoma[J]. J Cancer Res Clin Oncol. 2004;130(4):187\u201396.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"811_CR4","first-page":"111","volume":"79","author":"M Makuuchi","year":"2008","unstructured":"Makuuchi M, Donadon M, Torzilli G. Hepatic resection for hepatocellular carcinoma in cirrhosis[J]. Ann Ital Chir. 2008;79(2):111\u20135.","journal-title":"Ann Ital Chir"},{"issue":"3","key":"811_CR5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology. 2011;53(3):1020\u20132.","journal-title":"Hepatology"},{"issue":"4","key":"811_CR6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer","year":"2012","unstructured":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol. 2012;56(4):908\u201343.","journal-title":"J Hepatol"},{"issue":"11","key":"811_CR7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med. 1996;334(11):693\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"811_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jamcollsurg.2007.03.002","volume":"205","author":"H Lang","year":"2007","unstructured":"Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers[J]. J Am Coll Surg. 2007;205(1):27\u201336.","journal-title":"J Am Coll Surg"},{"issue":"7","key":"811_CR9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","volume":"146","author":"T Yau","year":"2014","unstructured":"Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma[J]. Gastroenterology. 2014;146(7):1691\u2013700.","journal-title":"Gastroenterology"},{"issue":"8","key":"811_CR10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1440-1746.2009.05847.x","volume":"24","author":"K Shirabe","year":"2009","unstructured":"Shirabe K, Kajiyama K, Abe T, et al. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio[J]. J Gastroenterol Hepatol. 2009;24(8):1431\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"811_CR11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3748\/wjg.v12.i5.828","volume":"12","author":"M Makuuchi","year":"2006","unstructured":"Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan[J]. World J Gastroenterol. 2006;12(5):828\u20139.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"811_CR12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archsurg.139.7.766","volume":"139","author":"T Aoki","year":"2004","unstructured":"Aoki T, Imamura H, Hasegawa K, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma[J]. Arch Surg. 2004;139(7):766\u201374.","journal-title":"Arch Surg"},{"issue":"2","key":"811_CR13","first-page":"178","volume":"35","author":"CH Cheng","year":"2012","unstructured":"Cheng CH, Yu MC, Wu TH, et al. Surgical resection of centrally located large hepatocellular carcinoma[J]. Chang Gung Med J. 2012;35(2):178\u201391.","journal-title":"Chang Gung Med J"},{"issue":"4","key":"811_CR14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/liv.12307","volume":"34","author":"G Heng-Jun","year":"2014","unstructured":"Heng-Jun G, Yao-Jun Z, Min-Shan C, et al. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma[J]. Liver Int. 2014;34(4):612\u201320.","journal-title":"Liver Int"},{"issue":"4","key":"811_CR15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1245\/s10434-008-0282-7","volume":"16","author":"MC Ho","year":"2009","unstructured":"Ho MC, Huang GT, Tsang YM, et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas[J]. Ann Surg Oncol. 2009;16(4):848\u201355.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"811_CR16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1245\/s10434-011-2060-1","volume":"19","author":"CY Hsu","year":"2012","unstructured":"Hsu CY, Hsia CY, Huang YH, et al. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis[J]. Ann Surg Oncol. 2012;19(3):842\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"811_CR17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11605-013-2440-x","volume":"18","author":"YJ Jin","year":"2014","unstructured":"Jin YJ, Lee JW, Choi YJ, et al. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A[J]. J Gastrointest Surg. 2014;18(3):555\u201361.","journal-title":"J Gastrointest Surg"},{"issue":"26","key":"811_CR18","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1097\/MD.0000000000000180","volume":"93","author":"L Jianyong","year":"2014","unstructured":"Jianyong L, Lunan Y, Wentao W, et al. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?[J]. Medicine (Baltimore). 2014;93(26):e180.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"811_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/bjs.5622","volume":"94","author":"SG Lee","year":"2007","unstructured":"Lee SG, Hwang S, Jung JP, et al. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions[J]. Br J Surg. 2007;94(3):320\u20136.","journal-title":"Br J Surg"},{"issue":"11","key":"811_CR20","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1007\/s00268-014-2704-y","volume":"38","author":"C Lim","year":"2014","unstructured":"Lim C, Mise Y, Sakamoto Y, et al. Above 5\u00a0cm, size does not matter anymore in patients with hepatocellular carcinoma[J]. World J Surg. 2014;38(11):2910\u20138.","journal-title":"World J Surg"},{"issue":"9","key":"811_CR21","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00268-010-0598-x","volume":"34","author":"CT Lin","year":"2010","unstructured":"Lin CT, Hsu KF, Chen TW, et al. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?[J]. World J Surg. 2010;34(9):2155\u201361.","journal-title":"World J Surg"},{"issue":"5","key":"811_CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1245\/ASO.2005.06.004","volume":"12","author":"KK Ng","year":"2005","unstructured":"Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database[J]. Ann Surg Oncol. 2005;12(5):364\u201373.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"811_CR23","first-page":"2421","volume":"34","author":"K Nojiri","year":"2014","unstructured":"Nojiri K, Tanaka K, Takeda K, et al. The efficacy of liver resection for multinodular hepatocellular carcinoma[J]. Anticancer Res. 2014;34(5):2421\u20136.","journal-title":"Anticancer Res"},{"issue":"10","key":"811_CR24","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1245\/s10434-007-9518-1","volume":"14","author":"D Pandey","year":"2007","unstructured":"Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10\u00a0cm or more) after surgical resection[J]. Ann Surg Oncol. 2007;14(10):2817\u201323.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"811_CR25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1072-7515(02)01163-8","volume":"194","author":"RT Poon","year":"2002","unstructured":"Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10\u00a0cm in diameter[J]. J Am Coll Surg. 2002;194(5):592\u2013602.","journal-title":"J Am Coll Surg"},{"issue":"7","key":"811_CR26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","volume":"44","author":"JH Wang","year":"2008","unstructured":"Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma\u2014survival analysis of 3892 patients[J]. Eur J Cancer. 2008;44(7):1000\u20136.","journal-title":"Eur J Cancer"},{"issue":"1","key":"811_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","volume":"61","author":"L Yin","year":"2014","unstructured":"Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT[J]. J Hepatol. 2014;61(1):82\u20138.","journal-title":"J Hepatol"},{"issue":"2","key":"811_CR28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SLA.0000000000000236","volume":"260","author":"JH Zhong","year":"2014","unstructured":"Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg. 2014;260(2):329\u201340.","journal-title":"Ann Surg"},{"issue":"7","key":"811_CR29","doi-asserted-by":"crossref","first-page":"e68193","DOI":"10.1371\/journal.pone.0068193","volume":"8","author":"JH Zhong","year":"2013","unstructured":"Zhong JH, Xiang BD, Gong WF, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PLoS One. 2013;8(7):e68193.","journal-title":"PLoS One"},{"issue":"5","key":"811_CR30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.surg.2012.03.024","volume":"152","author":"WT Chang","year":"2012","unstructured":"Chang WT, Kao WY, Chau GY, et al. Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?[J]. Surgery. 2012;152(5):809\u201320.","journal-title":"Surgery"},{"issue":"2","key":"811_CR31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jss.2012.04.058","volume":"178","author":"J Huang","year":"2012","unstructured":"Huang J, Hernandez-Alejandro R, Croome KP, et al. Hepatic resection for huge (>15\u00a0cm) multinodular HCC with macrovascular invasion[J]. J Surg Res. 2012;178(2):743\u201350.","journal-title":"J Surg Res"},{"issue":"1","key":"811_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1055-3207(02)00082-0","volume":"12","author":"I Ikai","year":"2003","unstructured":"Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and\/or hepatic veins[J]. Surg Oncol Clin N Am. 2003;12(1):65\u201375.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"811_CR33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.surg.2004.12.012","volume":"137","author":"TM Pawlik","year":"2005","unstructured":"Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study[J]. Surgery. 2005;137(4):403\u201310.","journal-title":"Surgery"},{"issue":"8","key":"811_CR34","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1245\/s10434-010-0940-4","volume":"17","author":"J Shi","year":"2010","unstructured":"Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus[J]. Ann Surg Oncol. 2010;17(8):2073\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"811_CR35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","volume":"257","author":"G Torzilli","year":"2013","unstructured":"Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East\u2013west study group[J]. Ann Surg. 2013;257(5):929\u201337.","journal-title":"Ann Surg"},{"issue":"7","key":"811_CR36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00432-012-1188-0","volume":"138","author":"T Yang","year":"2012","unstructured":"Yang T, Lin C, Zhai J, et al. Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging[J]. J Cancer Res Clin Oncol. 2012;138(7):1121\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"811_CR37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.amjsurg.2011.05.010","volume":"203","author":"L Liu","year":"2012","unstructured":"Liu L, Miao R, Yang H, et al. Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China[J]. Am J Surg. 2012;203(6):741\u201350.","journal-title":"Am J Surg"},{"issue":"3","key":"811_CR38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2008.18.8151","volume":"27","author":"SL Chan","year":"2009","unstructured":"Chan SL, Mo FK, Johnson PJ, et al. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy[J]. J Clin Oncol. 2009;27(3):446\u201352.","journal-title":"J Clin Oncol"},{"issue":"35","key":"811_CR39","doi-asserted-by":"crossref","first-page":"e1426","DOI":"10.1097\/MD.0000000000001426","volume":"94","author":"JH Zhong","year":"2015","unstructured":"Zhong JH, You XM, Lu SD, et al. Historical comparison of overall survival after hepatic resection for patients with large and\/or multinodular hepatocellular carcinoma[J]. Medicine (Baltimore). 2015;94(35):e1426.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"811_CR40","first-page":"4","volume":"3","author":"F Feo","year":"2015","unstructured":"Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?[J]. Ann Transl Med. 2015;3(1):4.","journal-title":"Ann Transl Med"},{"issue":"2","key":"811_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jamcollsurg.2005.10.005","volume":"202","author":"SA Shah","year":"2006","unstructured":"Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes[J]. J Am Coll Surg. 2006;202(2):275\u201383.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"811_CR42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification[J]. Semin Liver Dis. 1999;19(3):329\u201338.","journal-title":"Semin Liver Dis"},{"issue":"11","key":"811_CR43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/archsurg.138.11.1198","volume":"138","author":"H Imamura","year":"2003","unstructured":"Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8\u00a0years[J]. Arch Surg. 2003;138(11):1198\u2013206.","journal-title":"Arch Surg"},{"issue":"7","key":"811_CR44","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","volume":"134","author":"T Ishizawa","year":"2008","unstructured":"Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma[J]. Gastroenterology. 2008;134(7):1908\u201316.","journal-title":"Gastroenterology"},{"issue":"23","key":"811_CR45","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.3748\/wjg.v11.i23.3644","volume":"11","author":"HY Cheng","year":"2005","unstructured":"Cheng HY, Wang X, Chen D, et al. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma[J]. World J Gastroenterol. 2005;11(23):3644\u20136.","journal-title":"World J Gastroenterol"},{"issue":"9 Pt 2","key":"811_CR46","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1051-0443(07)61789-8","volume":"13","author":"DE Ramsey","year":"2002","unstructured":"Ramsey DE, Kernagis LY, Soulen MC, et al. Chemoembolization of hepatocellular carcinoma[J]. J Vasc Interv Radiol. 2002;13(9 Pt 2):S211\u201321.","journal-title":"J Vasc Interv Radiol"},{"issue":"5B","key":"811_CR47","first-page":"3685","volume":"26","author":"M Kaibori","year":"2006","unstructured":"Kaibori M, Tanigawa N, Matsui Y, et al. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction[J]. Anticancer Res. 2006;26(5B):3685\u201392.","journal-title":"Anticancer Res"},{"issue":"5","key":"811_CR48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cgh.2014.03.038","volume":"13","author":"WE Naugler","year":"2015","unstructured":"Naugler WE, Alsina AE, Frenette CT, et al. Building the multidisciplinary team for management of patients with hepatocellular carcinoma[J]. Clin Gastroenterol Hepatol. 2015;13(5):827\u201335.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"811_CR49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1477-7819-11-240","volume":"11","author":"S Jiang","year":"2013","unstructured":"Jiang S, Liu Y, Wang L, et al. A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma[J]. World J Surg Oncol. 2013;11:240.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"811_CR50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1440-1746.2010.06329.x","volume":"26","author":"SL Chan","year":"2011","unstructured":"Chan SL, Mo FK, Johnson PJ, et al. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population[J]. J Gastroenterol Hepatol. 2011;26(2):340\u20137.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0811-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T07:25:55Z","timestamp":1498289155000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjso.com\/content\/14\/1\/62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0811-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]},"article-number":"62"}}